Recombinant CEACAM5 (Labetuzumab Biosimilar) antibody

Catalog No. ABIN7597766

This anti-CEACAM5 (Labetuzumab Biosimilar) antibody is a Humanized Chimeric antibody detecting CEACAM5 (Labetuzumab Biosimilar) in . Suitable for Human.

Quick Overview for Recombinant CEACAM5 (Labetuzumab Biosimilar) antibody (ABIN7597766)

Target: CEACAM5 (Labetuzumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Conjugate: This CEACAM5 (Labetuzumab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-CEACAM5 (Labetuzumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Labetuzumab Biosimilar Antibody

Specificity: Meconium antigen 100, CEACAM5, CEA, CD66e, Carcinoembryonic antigen-related cell adhesion molecule 5, Carcinoembryonic antigen

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for CEACAM5 (Labetuzumab Biosimilar)

Target: CEACAM5 (Labetuzumab Biosimilar)

Alternative Name: Labetuzumab Biosimilar

Target Type: Biosimilar

Background: Meconium antigen 100, CEACAM5, CEA, CD66e, Carcinoembryonic antigen-related cell adhesion molecule 5, Carcinoembryonic antigen

UniProt: P06731

CAS-No: 219649-07-7